Sio Capital Management’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-31,769
| Closed | -$76.2K | – | 57 |
|
|
2024
Q2 | $76.2K | Hold |
31,769
| – | – | 0.02% | 45 |
|
|
2024
Q1 | $156K | Hold |
31,769
| – | – | 0.05% | 48 |
|
|
2023
Q4 | $133K | Hold |
31,769
| – | – | 0.03% | 39 |
|
|
2023
Q3 | $478K | Hold |
31,769
| – | – | 0.15% | 43 |
|
|
2023
Q2 | $928K | Hold |
31,769
| – | – | 0.24% | 34 |
|
|
2023
Q1 | $732K | Hold |
31,769
| – | – | 0.36% | 35 |
|
|
2022
Q4 | $457K | Hold |
31,769
| – | – | 0.17% | 39 |
|
|
2022
Q3 | $761K | Hold |
31,769
| – | – | 0.24% | 38 |
|
|
2022
Q2 | $629K | Hold |
31,769
| – | – | 0.24% | 47 |
|
|
2022
Q1 | $1.14M | Hold |
31,769
| – | – | 0.38% | 46 |
|
|
2021
Q4 | $1.42M | Hold |
31,769
| – | – | 0.43% | 50 |
|
|
2021
Q3 | $2.26M | Sell |
31,769
-5,444
| -15% | -$619K | 0.72% | 39 |
|
|
2021
Q2 | $4.91M | Buy |
37,213
+1,000
| +3% | +$125K | 1.22% | 26 |
|
|
2021
Q1 | $4.85M | Buy |
36,213
+1,397
| +4% | +$177K | 0.99% | 32 |
|
|
2020
Q4 | $2.55M | Buy |
34,816
+392
| +1% | +$28.8K | 0.52% | 60 |
|
|
2020
Q3 | $2.62M | Hold |
34,424
| – | – | 0.52% | 51 |
|
|
2020
Q2 | $2.75M | Buy |
34,424
+2,051
| +6% | +$139K | 0.8% | 45 |
|
|
2020
Q1 | $1.32M | Buy |
32,373
+6,924
| +27% | +$526K | 0.44% | 46 |
|
|
2019
Q4 | $2.07M | Buy |
+25,449
| New | +$1.82M | 0.49% | 42 |
|
Other funds holding ASLN
Sio Capital Management's ASLN Position: Q3 2024 in Review
Sio Capital Management sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2024, closing a stake of 31,769 shares — an estimated $76.2K sold.
Sio Capital Management first reported a position in ASLN in Q4 2019 and held it in 19 quarters. The position peaked at $4.91M in Q2 2021. 1 fund tracked by Wall St. Rank holds ASLN as of Q3 2024.
- Sio Capital Management reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2024 after selling out during the quarter.
- Sio Capital Management sold 31,769 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2024, an estimated $76.2K.
- Sio Capital Management first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2019 and held it in 19 quarters.
- Sio Capital Management's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $4.91M in Q2 2021.
- 1 fund tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2024.
Based on Sio Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.